BRWM
LJPC

B. Riley Wealth Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

B. Riley Wealth Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-38
Closed – – 1051
2015
Q2 		$0 Buy
+38
New +$783 ﹤0.01% 1150

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

B. Riley Wealth Management's LJPC Position: Q3 2015 in Review

B. Riley Wealth Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2015, closing a stake of 38 shares.

B. Riley Wealth Management first reported a position in LJPC in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 72 funds tracked by Wall St. Rank hold LJPC as of Q3 2015.

  • B. Riley Wealth Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 38 La Jolla Pharmaceutical Company shares in Q3 2015.
  • B. Riley Wealth Management first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 1 quarter.
  • B. Riley Wealth Management's La Jolla Pharmaceutical Company position peaked at $0 in Q2 2015.
  • 72 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.